| Fund ID | 805-8154117638 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | Yes |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 65% |
| Fund | Type | Gross assets |
|---|---|---|
| Sagard Healthcare Royalty Partners LP | Private Equity | $353.6M |
| Sagard Healthcare Partners (892) Holdings, LP | Private Equity | $320.2M |
| Portage Capital Solutions Fund I LP | Private Equity | $237M |
Portag3 Ventures II International (fi) LP reports $81.5 million in gross assets, among the top 46% of private funds by size.
The stated minimum investment is $15 million.
Portag3 Ventures II International (fi) LP is managed by Sagard Holdings Manager LP.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.